Deutsche Health and Wellness S
(SCHLX)
US Markets Closed
AdChoices
42.09
+0.73
+1.76%
:

Previous Close

41.36

Net Assets

228.89M

Yield

0.00%

Front load

None

Expenses

1.09%

Category

Health

Morningstar Risk

Average

Morningstar Rating ★★★
AdChoices
Performance
Returns %
Key statistics
  • Composition
  • Performance
  • Top Holdings
  • Top Rated Funds
  • Fund vs. Category
Quarterly Returns
  • Annual

  • SCHLX

  • Category

    • 2013

    • 47.06%

    • -

    • 2012

    • 17.90%

    • -

    • 2011

    • 8.43%

    • -

    • 2010

    • 7.67%

    • -

    • 2013

    • 2012

    • 2011

      • Q1

      • 15.38%

      • 12.25%

      • 6.98%

      • Q2

      • 3.66%

      • 0.96%

      • 6.68%

      • Q3

      • 11.48%

      • 5.15%

      • -13.46%

      • Q4

      • 10.30%

      • -1.06%

      • 9.78%

      Composition
      Sector Weightings
      Equity Investment Style
      The two dimensions of the Fund Style box measure the average size of companies that have been in the FUND, from the top to bottom, and the average valuation characteristics of the FUND's past stock holdings, from left to right.
      • Name

      • % Portfolio Weight

      • Shares Held

      • Change

        • Gilead Sciences Inc

        • 4.42

        • 136,989

        • 0

        • Merck & Co Inc

        • 3.27

        • 181,067

        • 0

        • Biogen Idec Inc

        • 3.22

        • 31,316

        • 0

        • Actavis PLC

        • 3.18

        • 46,652

        • 0

        • Celgene Corp

        • 3.06

        • 107,467

        • 10,485

        • Johnson & Johnson

        • 3.00

        • 96,238

        • 0

        • Bristol-Myers Squibb Company

        • 2.95

        • 194,057

        • 0

        • AbbVie Inc

        • 2.41

        • 145,016

        • 0

        • Amgen Inc

        • 2.39

        • 57,165

        • 0

        • Pfizer Inc

        • 2.33

        • 264,176

        • 0

        • Name

        • Rating

        • YTD Return %

          • VALIC Company I Health Sciences

          • ★★★★★
          • 18.51

          • Prudential Jennison Health Sciences Z

          • ★★★★★
          • 17.77

          • Prudential Jennison Health Sciences A LW

          • ★★★★★
          • 17.50

          • T. Rowe Price Health Sciences

          • ★★★★★
          • 18.82

          • Janus Global Life Sciences A

          • ★★★★
          • 19.40

          • Janus Global Life Sciences I

          • ★★★★
          • 19.67

          • Franklin Biotechnology Discovery A

          • ★★★★
          • 19.71

          • Fidelity Advisor® Health Care B

          • ★★★★
          • 19.41

          • Prudential Jennison Health Sciences C

          • ★★★★
          • 16.80

          • Fidelity Advisor® Biotechnology A

          • ★★★★
          • 18.97

          • Name

          • SCHLX

          • Category

            • Expense Ratio

            • 1.09%

            • 1.45%

            • Net Assets

            • 228.89M

            • 711.24M

            • Dividend Yield

            • 0.98%

            • 0.61

            • Price/Book

            • 3.69

            • 4.82

            • Price/Sales

            • 1.84

            • 3.25

            • Price/Cash Flow

            • 17.07

            • 19.29

            Profile

            Name of Issuer

            Deutsche Asset & Wealth Mngt

            Fund Style

            Open

            Fund Manager

            Brendan O'Neill

            Investment Style

            Large Growth

            The investment seeks long-term growth of capital. Under normal circumstances, the fund will invest at least 80% of net assets, plus the amount of any borrowings for investment purposes, in equity securities of companies in the health care and wellness sectors. It invests primarily in securities of U.S. companies, but may invest in foreign companies as well. The fund may invest in companies of any size. While the fund invests mainly in common stocks, it may also invest up to 20% of total assets in U.S. Treasury and U.S. agency debt obligations.

            Purchase Information

            Initial Purchase 2,500
            Initial Purchase: IRA 1,000
            Initial Purchase: AIP 1,000
            Front load None
            Back Load None

            Inception

            3/2/1998